Connor, Clark & Lunn Investment Management (CC&L)’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $418K | Sell |
|
|||||
|
2025
Q3 | $889K | Sell |
|
|||||
|
2025
Q2 | $734K | Buy |
|
|||||
|
2025
Q1 | $1.24M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $126K | Sell |
|
|||||
|
2023
Q3 | $278K | Buy |
|
|||||
|
2023
Q2 | $231K | Sell |
|
|||||
|
2023
Q1 | $333K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $29K | Hold |
|
|||||
|
2016
Q2 | $32K | Sell |
|
|||||
|
2016
Q1 | $43K | Hold |
|
|||||
|
2015
Q4 | $52K | Buy |
|
|||||
|
2015
Q3 | $45K | Buy |
|
|||||
|
2015
Q2 | $35K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $235K | Buy |
|
|||||
|
2013
Q2 | $234K | Buy |
|